Carbidopa, Levodopa, And Entacapone Tablet, Film Coated
Product Images NDC 0781-5613

This is a medicine with NDC number 0781-5613-01 containing 100 tablets. The tablets have specific dosage instructions which can be found in the package insert. The tablets should be swallowed whole and not crushed or split. They contain a mixture of Carbidopa, Levodopa, and Entacapone and should be stored between 15°C to 30°C (59°F to 86°F). Each film-coated tablet contains 12.5 mg Carbidopa (USP), 50 mg Levodopa (USP), and 200 mg Entacapone. The medicine should be kept out of the reach of children. The manufacturer is Orion Corporation, Orion Pharma, 02200 Espoo, Finland, for Sandoz Inc, Princeton, NY 08540.*

This is a medication packaging label for a bottle of 100 tablets containing a combination of carbidopa, levodopa, and entacapone. Each film-coated tablet contains 18.75 mg of carbidopa, 75 mg of levodopa, and 200 mg of entacapone, and it is important to follow the usual dosage as listed in the package insert. The tablets should be swallowed whole and should not be crushed or split. The medication should be kept out of reach of children and only dispensed in a tight container. The product is manufactured by Orion Corporation in Finland for Sandoz Inc. in New Jersey.*

This is a medication with the NDC code 0781-5637-01 that comes in the form of 100 tablets. The usual dosage can be found in the package insert and the tablets should be swallowed whole, without crushing, splitting, or chewing them. The medication contains Carbidopa, Levodopa, and Entacapone, with each film-coated tablet consisting of 25 mg, 100 mg, and 200 mg of these ingredients, respectively. The tablets should be stored at a temperature between 15°C to 30°C (59°F to 86°F) and dispensed in a tight container. The medication should be kept out of the reach of children. It is manufactured by Orion Corporation and distributed by Sandoz Inc. Tablets should not be combined to achieve a higher strength due to the risk of entacapone overdose.*

This is a medication packaging for a drug called Curbidopu. It contains a combination of Carbidopa, Levodopa, and Entacapone. The package contains 100 tablets and the recommended dosage is mentioned in the package insert. These tablets should not be crushed or split and should be swallowed as a whole. Each tablet contains 31.25mg of Carbidopa, 125mg of Levodopa, and 200mg Entacapone. The tablets should be stored between 15°C to 30°C (59°F to 86°F). It is manufactured by Orion Corporation, Orion Pharma, Espoo, Finland. This is a prescription-only medication and should be kept out of reach of children. The packaging also states that combining tablets to achieve a higher dose is not recommended as it may lead to Entacapone overdose.*

This is a medication with the NDC code 0781-5654-01. It comes in a container with 100 tablets and should be stored at temperatures between 25°C (77°F) and 30°C (86°F). The tablets contain Carbidopa, Levodopa, and Entacapone. Patients should follow the usual dosage instructions provided in the package insert and swallow the tablet whole without crushing or splitting it. The tablets should be stored in a tight container and kept out of reach of children. It is manufactured by Orion Corporation in Espoo, Finland and Orion Pharma in Ainiand and distributed by Sandoz in Princeton, NJ. Patients are advised not to combine tablets to increase the tablet's strength due to the risk of Entacapone overdose.*